Olema Oncology is a biopharmaceutical company developing innovative targeted therapies for women’s cancers. Their lead program, OP-1250, a potential best-in-class complete estrogen receptor antagonist (CERAN), is in development to treat estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) breast cancer. Olema recently initiated a Phase 1/2 dose-escalation and expansion clinical trial of OP-1250. They are supported in their mission by experienced and accomplished scientists and board members, leading healthcare investors and some of the most innovative pharma companies.

Biotechnology

Olema Oncology

Olema Oncology's headquarters in San Francisco, CA, United States

This department oversees clinical programs and regulatory compliance, ensuring efficient operations and data management within clinical settings.

Clinical and Regulatory Operations

The Leadership Team at Olema Oncology is responsible for steering the strategic vision and operational execution of the company’s mission to develop innovative treatments for women’s cancers. Comprising senior executives from diverse areas such as clinical development, pharmacology, and operations, the team collaborates to advance clinical trials, optimize resource allocation, and foster a culture of innovation and excellence. Their collective expertise is pivotal in guiding Olema through the complexities of drug development and bringing transformative therapies like OP-1250 to market.

Leadership Team

The Clinical Development Team at Olema Oncology is responsible for the strategic planning, execution, and management of clinical trials, including the ongoing Phase 1/2 trial of OP-1250. This team ensures the rigorous design and implementation of clinical studies while maintaining compliance with regulatory standards. Their collective efforts aim to advance OP-1250 through the clinical development pipeline, ultimately contributing to the availability of innovative therapies for women's cancers.

Clinical Development Team

The Clinical and Pharmacology team at Olema Oncology is responsible for designing, implementing, and managing clinical trials and pharmacology studies to evaluate the safety, efficacy, and pharmacokinetics of investigational therapies like OP-1250. This team ensures compliance with regulatory standards, analyzes clinical data, and communicates findings to support the advancement of novel treatments for women’s cancers. Their multidisciplinary expertise spans pre-clinical and clinical development, quality management, medical affairs, and data management.

Clinical and Pharmacology

This department manages and supports the planning, execution, and oversight of clinical trials to ensure the safety and efficacy of new therapies.

Clinical Research

This department focuses on the development and implementation of analytical methods for the assessment of chemical and biological products.

��

People (11)

Jobs (0)

Other teams

Leadership Team

Clinical Development Team

Clinical and Pharmacology

Clinical Research

Analytical Development

��������

People (11)

Jobs (0)

Other teams

Leadership Team

Clinical Development Team

Clinical and Pharmacology

Clinical Research

Analytical Development

��